Cyclosporin a form 2 and method of making same

US10017541B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10017541-B2
Application numberUS-201615165997-A
CountryUS
Kind codeB2
Filing dateMay 26, 2016
Priority dateNov 15, 2011
Publication dateJul 10, 2018
Grant dateJul 10, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed herein are methods of making cyclosporin A Form 2.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for making cyclosporin A form 2, the method comprising the steps of: a) preparing a suspension of cyclosporin A in a solvent comprising an ingredient selected from the group consisting of 1,4-dioxane and ethanol; b) heating the suspension; c) adding cyclosporin A form 2 to the suspension; d) stirring the suspension; and e) isolating cyclosporin A form 2 from the suspension. 2. The method of claim 1 , wherein the step of heating the suspension comprises heating the suspension at a temperature of between 40° C. and 70° C. 3. The method of claim 2 , wherein the step of heating the suspension comprises heating the suspension at a temperature of between 60° C. and 65° C. 4. The method of claim 1 , wherein the step of stirring the suspension comprises stirring the suspension at a temperature of between 20° C. and 70° C. 5. The method of claim 4 , wherein the step of stirring the suspension comprises stirring the suspension at a temperature of between 60° C. and 65° C. 6. The method of claim 5 , wherein the step of stirring the suspension comprises stirring the suspension for between 24 hours and 72 hours. 7. The method of claim 5 , wherein the step of stirring the suspension comprises stirring the suspension for between 22 hours and 23 hours.

Assignees

Inventors

Classifications

  • Antiallergic agents (antiasthmatic agents A61P11/06; ophthalmic antiallergics A61P27/14) · CPC title

  • Ophthalmic agents · CPC title

  • C07K7/645Primary

    Cyclosporins; Related peptides · CPC title

  • Cyclosporins · CPC title

  • by crystallization · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10017541B2 cover?
Disclosed herein are methods of making cyclosporin A Form 2.
Who is the assignee on this patent?
Allergan Inc
What technology area does this patent fall under?
Primary CPC classification C07K7/645. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).